Similar Articles
781 Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
782 Cancer prevention in patients with human immunodeficiency virus infection
783 Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
784 Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
785 Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
786 Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
787 Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
788 Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
789 Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib
790 Contemporary role of liver biopsy in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA